JPS6238657B2 - - Google Patents
Info
- Publication number
- JPS6238657B2 JPS6238657B2 JP9616978A JP9616978A JPS6238657B2 JP S6238657 B2 JPS6238657 B2 JP S6238657B2 JP 9616978 A JP9616978 A JP 9616978A JP 9616978 A JP9616978 A JP 9616978A JP S6238657 B2 JPS6238657 B2 JP S6238657B2
- Authority
- JP
- Japan
- Prior art keywords
- creatinine
- bilirubin
- rate
- picrate
- biological sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 146
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 82
- 229940109239 creatinine Drugs 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 42
- 238000006243 chemical reaction Methods 0.000 claims description 26
- 229940075930 picrate Drugs 0.000 claims description 18
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 17
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 claims description 14
- 239000012472 biological sample Substances 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims description 9
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 claims description 4
- CEJLBZWIKQJOAT-UHFFFAOYSA-N dichloroisocyanuric acid Chemical compound ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 claims description 4
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 description 17
- 238000005259 measurement Methods 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- 238000001228 spectrum Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 239000007800 oxidant agent Substances 0.000 description 11
- 230000003647 oxidation Effects 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000012085 test solution Substances 0.000 description 6
- 238000010876 biochemical test Methods 0.000 description 5
- 238000004737 colorimetric analysis Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000011533 pre-incubation Methods 0.000 description 3
- 239000003223 protective agent Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 2
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- ICYOLCFDSJJLAC-UHFFFAOYSA-N gramine Chemical compound C1=CC=C[C]2C(CN(C)C)=CN=C21 ICYOLCFDSJJLAC-UHFFFAOYSA-N 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- -1 permanganate Chemical compound 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9616978A JPS5523445A (en) | 1978-08-09 | 1978-08-09 | Measuring method for reaction rate of creatinine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9616978A JPS5523445A (en) | 1978-08-09 | 1978-08-09 | Measuring method for reaction rate of creatinine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5523445A JPS5523445A (en) | 1980-02-19 |
| JPS6238657B2 true JPS6238657B2 (cs) | 1987-08-19 |
Family
ID=14157822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9616978A Granted JPS5523445A (en) | 1978-08-09 | 1978-08-09 | Measuring method for reaction rate of creatinine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5523445A (cs) |
-
1978
- 1978-08-09 JP JP9616978A patent/JPS5523445A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5523445A (en) | 1980-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3523878B2 (ja) | ヘモグロビンの定量用無シアン化物試薬及び方法 | |
| JPS60200167A (ja) | 化学発光法による過酸化水素の定量法 | |
| EP0517914B1 (en) | Reagent and methods for calcium determination | |
| Sugita et al. | Reference values of serum and urine creatinine, and of creatinine clearance by a new enzymatic method | |
| JP5082850B2 (ja) | 鉄濃度測定法 | |
| EP4062179B1 (en) | Fluorimetric analytical method for the determination of creatinine in clinically significant biological samples and a fluorimetric reagent for use in this method | |
| JP2796462B2 (ja) | エタノール分析用組成物 | |
| EP0140589B1 (en) | Enzymatic determination of d-3-hydroxybutyric acid or acetoacetic acid, and reagents therefor | |
| US6326208B1 (en) | Assay for total and direct bilirubin | |
| Wong et al. | Colorimetric determination of potassium in whole blood, serum, and plasma. | |
| JP2694004B2 (ja) | 血清又は血漿中のフルクトサミンの測定法 | |
| CA1324066C (en) | Simultaneous assay for calcium and phosphorus | |
| US4447544A (en) | Method and reagent for determining inorganic phosphate in biological sample | |
| Kamoun et al. | Ultramicromethod for determination of plasma uric acid. | |
| Hashim et al. | Wet vs. dry chemical analysis of renal stones | |
| JPH0772157A (ja) | 糖化蛋白の定量方法およびその定量用キット | |
| EP0243125A2 (en) | Method of measuring phenol and alpha-naphthol, and method of measuring the activity of enzymes | |
| JP2005300435A (ja) | カルシウムの測定方法および測定試薬 | |
| JPS63291595A (ja) | 生体試料中のグルコ−スの測定方法 | |
| Bostick et al. | Simultaneous determination of silica and phosphate in water from a single experiment using a miniature centrifugal fast analyzer | |
| JPH04271799A (ja) | クレアチニンを酵素により測定する方法および試薬 | |
| JP4820289B2 (ja) | カルボニックアンヒドラーゼi活性の測定法 | |
| Pesce et al. | Enzyme immunoassay and enzyme inhibition assay of methotrexate, with use of the centrifugal analyzer. | |
| JPS633262B2 (cs) | ||
| JPH11243993A (ja) | 生体成分の測定におけるビリルビンの干渉を回避する方法 |